Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.

Rejin KebudiFatma Betul CakirSema Buyukkapu BayOmer GorgunPelin AltınokAyça IribasFulya Yaman AgaogluEmin Darendeliler

Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2018)

Nimotuzumab-containing regimens are feasible and tolerable; it might be that some patients either with newly diagnosed DIPG or with progressive disease may benefit modestly from nimotuzumab-containing combinations.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
multiple sclerosis
prognostic factors
high grade
peritoneal dialysis
low grade
young adults